These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 11280541

  • 21. Infliximab use in luminal Crohn's disease.
    Richter JA, Bickston SJ.
    Gastroenterol Clin North Am; 2006 Dec; 35(4):775-93. PubMed ID: 17129813
    [Abstract] [Full Text] [Related]

  • 22. [Treatment with chimeric monoclonal antitumor necrosis factor (infliximab) of patients with active steroid-dependent/resistant Crohn's disease and fistulas].
    Martorana G, Casà A, Oliva L, Orlando A, Cottone M.
    Recenti Prog Med; 2001 Dec; 92(7-8):451-5. PubMed ID: 11475786
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease.
    Baert F, Noman M, Vermeire S, Van Assche G, D' Haens G, Carbonez A, Rutgeerts P.
    N Engl J Med; 2003 Feb 13; 348(7):601-8. PubMed ID: 12584368
    [Abstract] [Full Text] [Related]

  • 29. Infliximab for the treatment of fistulas in patients with Crohn's disease.
    Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, van Hogezand RA, Podolsky DK, Sands BE, Braakman T, DeWoody KL, Schaible TF, van Deventer SJ.
    N Engl J Med; 1999 May 06; 340(18):1398-405. PubMed ID: 10228190
    [Abstract] [Full Text] [Related]

  • 30. Infliximab and surgical treatment of complex anal Crohn's disease.
    Duff S, Sagar PM, Rao M, Dolling S, Sprakes M, Hamlin PJ.
    Colorectal Dis; 2012 Aug 06; 14(8):972-6. PubMed ID: 21899707
    [Abstract] [Full Text] [Related]

  • 31. [Treatment of Crohn's disease with anti-TNF alpha antibodies (infliximab): results of a multicentric and retrospective study].
    Doubremelle M, Bourreille A, Zerbib F, Heresbach D, Metman EH, Beau P, Gournay J, Galmiche JP.
    Gastroenterol Clin Biol; 2002 Nov 06; 26(11):973-9. PubMed ID: 12483127
    [Abstract] [Full Text] [Related]

  • 32. Management of refractory fistulizing pouchitis with infliximab.
    Viscido A, Kohn A, Papi C, Caprilli R.
    Eur Rev Med Pharmacol Sci; 2004 Nov 06; 8(5):239-46. PubMed ID: 15638238
    [Abstract] [Full Text] [Related]

  • 33. Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease.
    Van Assche G, Vanbeckevoort D, Bielen D, Coremans G, Aerden I, Noman M, D'Hoore A, Penninckx F, Marchal G, Cornillie F, Rutgeerts P.
    Am J Gastroenterol; 2003 Feb 06; 98(2):332-9. PubMed ID: 12591051
    [Abstract] [Full Text] [Related]

  • 34. Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine.
    Egan LJ, Sandborn WJ, Tremaine WJ.
    Am J Gastroenterol; 1998 Mar 06; 93(3):442-8. PubMed ID: 9517654
    [Abstract] [Full Text] [Related]

  • 35. [Treatment of Crohn's disease by infliximab. About 20 cases].
    Serghini M, Karoui S, Meknini M, Matri S, Kallel L, Fekih M, Boubaker J, Filali A.
    Tunis Med; 2009 Sep 06; 87(9):579-82. PubMed ID: 20180377
    [Abstract] [Full Text] [Related]

  • 36. Safety and steroid-sparing experience using infliximab for Crohn's disease at a pediatric inflammatory bowel disease center.
    Stephens MC, Shepanski MA, Mamula P, Markowitz JE, Brown KA, Baldassano RN.
    Am J Gastroenterol; 2003 Jan 06; 98(1):104-11. PubMed ID: 12526944
    [Abstract] [Full Text] [Related]

  • 37. [Infliximab therapy in children and adolescents with refractory Crohn's disease in the Netherlands; experience with 23 patients].
    de Ridder L, Escher JC, Taminiau JA.
    Ned Tijdschr Geneeskd; 2002 Oct 05; 146(40):1879-83. PubMed ID: 12395595
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Does infliximab infusion impact results of operative treatment for Crohn's perianal fistulas?
    Gaertner WB, Decanini A, Mellgren A, Lowry AC, Goldberg SM, Madoff RD, Spencer MP.
    Dis Colon Rectum; 2007 Nov 05; 50(11):1754-60. PubMed ID: 17899271
    [Abstract] [Full Text] [Related]

  • 40. High serum tumor necrosis factor-alpha levels are associated with lack of response to infliximab in fistulizing Crohn's disease.
    Martínez-Borra J, López-Larrea C, González S, Fuentes D, Dieguez A, Deschamps EM, Pérez-Pariente JM, López-Vázquez A, de Francisco R, Rodrigo L.
    Am J Gastroenterol; 2002 Sep 05; 97(9):2350-6. PubMed ID: 12358255
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.